NICM
TECH icon

Neo Ivy Capital Management’s Bio-Techne TECH Stock Holding History

Neo Ivy Capital Management’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$799K Buy
+11,316
New +$611K 0.18% 179
2023
Q4 		– Sell
-5,672
Closed -$386K – 442
2023
Q3 		$386K Buy
+5,672
New +$448K 0.17% 191

Other funds holding TECH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.3B AUM 67.69% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Neo Ivy Capital Management's TECH Position: Q2 2026 in Review

Neo Ivy Capital Management opened a new position in Bio-Techne (TECH) in Q2 2026: 11,316 shares worth $799K. The stake represents 0.18% of the portfolio and ranks #179 among its holdings. This is a return to the name: Neo Ivy Capital Management previously reported a position in TECH as recently as Q3 2023.

Neo Ivy Capital Management first reported a position in TECH in Q3 2023 and has held it in 2 quarters since. 596 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Neo Ivy Capital Management held 11,316 shares of Bio-Techne worth $799K as of Q2 2026.
  • Bio-Techne was a new Neo Ivy Capital Management position in Q2 2026.
  • Bio-Techne made up 0.18% of Neo Ivy Capital Management's portfolio in Q2 2026, its #179 holding.
  • Neo Ivy Capital Management first reported a position in Bio-Techne in Q3 2023 and has held it in 2 quarters since.
  • 596 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Neo Ivy Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.